tiprankstipranks
Balaxi Pharmaceuticals Limited (IN:BALAXI)
:BALAXI
India Market
BALAXI
Balaxi Pharmaceuticals Limited
RESEARCH TOOLSreports

Balaxi Pharmaceuticals Limited (BALAXI) Ratios

0 Followers

Balaxi Pharmaceuticals Limited Ratios

IN:BALAXI's free cash flow for Q2 2026 was ₹0.48. For the 2026 fiscal year, IN:BALAXI's free cash flow was decreased by ₹ and operating cash flow was ₹0.04. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 3.96 4.45 3.88 3.64 2.23
Quick Ratio
 2.66 4.45 2.36 1.67 0.67
Cash Ratio
 0.64 0.72 1.15 0.53 0.11
Solvency Ratio
 0.14 0.34 >-0.01 0.84 0.76
Operating Cash Flow Ratio
 0.25 -0.69 0.09 0.11 0.54
Short-Term Operating Cash Flow Coverage
 0.45 -1.24 0.28 0.57 9.39
Net Current Asset Value
₹ 1.54B₹ 1.64B₹ 1.53B₹ 1.37B₹ 776.97M
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.17 0.08 0.06 0.02
Debt-to-Equity Ratio
 0.24 0.23 0.10 0.07 0.03
Debt-to-Capital Ratio
 0.19 0.19 0.09 0.07 0.03
Long-Term Debt-to-Capital Ratio
 0.08 0.08 0.00 <0.01 0.00
Financial Leverage Ratio
 1.35 1.34 1.28 1.31 1.56
Debt Service Coverage Ratio
 0.39 0.81 2.13 4.39 13.01
Interest Coverage Ratio
 4.54 12.40 27.86 117.26 355.31
Debt to Market Cap
 2.06 0.14 0.03 0.02 <0.01
Interest Debt Per Share
 11.84 10.19 4.00 2.62 0.72
Net Debt to EBITDA
 0.96 0.46 -0.94 -0.25 -0.06
Profitability Margins
Gross Profit Margin
45.55%43.92%46.67%39.83%29.99%
EBIT Margin
5.97%9.93%18.05%17.43%19.87%
EBITDA Margin
6.69%10.58%18.92%17.95%20.05%
Operating Profit Margin
6.01%12.60%19.37%17.43%18.01%
Pretax Profit Margin
4.92%9.93%0.84%16.92%19.51%
Net Profit Margin
3.42%8.68%-0.99%13.66%17.06%
Continuous Operations Profit Margin
3.42%8.68%-0.99%13.66%17.06%
Net Income Per EBT
69.67%87.45%-118.44%80.75%87.41%
EBT Per EBIT
81.83%78.77%4.31%97.09%108.37%
Return on Assets (ROA)
2.93%8.08%-0.92%19.18%27.01%
Return on Equity (ROE)
4.12%10.82%-1.19%25.13%42.11%
Return on Capital Employed (ROCE)
6.32%14.23%22.89%31.43%44.44%
Return on Invested Capital (ROIC)
3.90%11.12%-24.95%24.00%37.64%
Return on Tangible Assets
3.24%8.84%-1.03%21.52%31.28%
Earnings Yield
7.81%6.77%-0.42%8.23%12.87%
Efficiency Ratios
Receivables Turnover
 2.50 2.61 4.33 6.43 10.14
Payables Turnover
 7.68 10.54 4.43 5.86 3.98
Inventory Turnover
 1.92 0.00 1.57 1.93 1.98
Fixed Asset Turnover
 5.77 7.95 14.80 17.69 53.70
Asset Turnover
 0.86 0.93 0.93 1.40 1.58
Working Capital Turnover Ratio
 3.10 1.68 1.63 3.08 4.08
Cash Conversion Cycle
 288.22 105.38 234.97 183.86 128.54
Days of Sales Outstanding
 145.78 140.01 84.26 56.72 36.00
Days of Inventory Outstanding
 189.97 0.00 233.07 189.38 184.19
Days of Payables Outstanding
 47.52 34.63 82.37 62.25 91.65
Operating Cycle
 335.75 140.01 317.33 246.10 220.19
Cash Flow Ratios
Operating Cash Flow Per Share
 2.94 -6.83 0.92 1.15 6.48
Free Cash Flow Per Share
 0.51 -10.65 0.63 -1.69 1.29
CapEx Per Share
 2.44 3.82 0.30 2.84 5.19
Free Cash Flow to Operating Cash Flow
 0.17 1.56 0.68 -1.47 0.20
Dividend Paid and CapEx Coverage Ratio
 1.21 -1.79 3.10 0.39 1.25
Capital Expenditure Coverage Ratio
 1.21 -1.79 3.10 0.41 1.25
Operating Cash Flow Coverage Ratio
 0.26 -0.71 0.25 0.46 9.39
Operating Cash Flow to Sales Ratio
 0.05 -0.13 0.02 0.02 0.12
Free Cash Flow Yield
9.73%-15.90%0.58%-1.59%1.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.81 14.77 -239.62 12.15 7.77
Price-to-Sales (P/S) Ratio
 0.10 1.28 2.37 1.66 1.33
Price-to-Book (P/B) Ratio
 0.51 1.60 2.84 3.05 3.27
Price-to-Free Cash Flow (P/FCF) Ratio
 10.27 -6.29 173.50 -62.74 54.46
Price-to-Operating Cash Flow Ratio
 8.08 -9.80 117.54 91.95 10.85
Price-to-Earnings Growth (PEG) Ratio
 -0.37 -0.01 2.28 -3.13 0.31
Price-to-Fair Value
 0.51 1.60 2.84 3.05 3.27
Enterprise Value Multiple
 2.40 12.58 11.59 9.00 6.55
Enterprise Value
 441.60M 3.84B 5.29B 5.44B 3.67B
EV to EBITDA
 2.40 12.58 11.59 9.00 6.55
EV to Sales
 0.16 1.33 2.19 1.62 1.31
EV to Free Cash Flow
 17.13 -6.53 160.49 -61.06 53.94
EV to Operating Cash Flow
 2.95 -10.17 108.73 89.50 10.74
Tangible Book Value Per Share
 40.71 37.08 33.13 29.76 16.91
Shareholders’ Equity Per Share
 46.83 41.92 38.23 34.72 21.49
Tax and Other Ratios
Effective Tax Rate
 0.30 0.13 2.18 0.19 0.13
Revenue Per Share
 54.24 52.24 45.81 63.88 53.05
Net Income Per Share
 1.86 4.53 -0.45 8.73 9.05
Tax Burden
 0.70 0.87 -1.18 0.81 0.87
Interest Burden
 0.82 1.00 0.05 0.97 0.98
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.21 0.16 0.12 0.09 0.05
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.01 -1.51 2.41 0.11 0.63
Currency in INR